Self-expanding metallic stent insertion for malignant bowel obstruction secondary to gynecologic malignancies: a retrospective analysis
Surgical Endoscopy · 2025
DOI: 10.1007/s00464-024-11483-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Endoscopy, 2025. Verfasst von Eliahu Yonathan Bekhor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Rabin Medica Center, Petah Tikva, Israel. elibekhor@gmail.com. Hauptthemen laut MEDLINE: Intestinal Obstruction, Genital Neoplasms, Female, Self Expandable Metallic Stents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Malignant bowel obstruction (MBO) is a common complication in advanced and recurrent gynecologic malignancies, with limited treatment options and poor prognosis. Self-expanding metallic stent (SEMS) insertion has emerged as an alternative palliative measure, yet data specific to gynecologic malignancies remains scarce. METHODS: A retrospective analysis was conducted on 61 patients with gynecologic malignancies and malignant large bowel obstruction who underwent colorectal stenting between January 2002 and December 2023. Data, including demographics, procedural details, clinical outcomes, and complications, were collected from electronic medical records. RESULTS: The mean age of patients was 65.7 years, with ovarian cancer being the most common malignancy (77%). "Technical success" of SEMS insertion was achieved in 91.4% of cases, with a "clinical success" rate of 76.7%. Major complications occurred in 2% and 5% of patients at 30- and 90 days post-procedure, respectively. Overall mortality rates were 4% at 30 days and 28% at 90 days. CONCLUSION: SEMS for managing MBO is a promising alternative to surgery in patients with advanced or recurrent gynecologic malignancies. It offers high technical and clinical success rates with acceptable complication rates. Further research is needed to delineate optimal patient selection criteria and refine procedural techniques to maximize outcomes in this challenging population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Rabin Medica Center, Petah Tikva, Israel. elibekhor@gmail.com.
- Faculty of Medicine, Tel Aviv University, 38955, Kfar Haroe, Israel. elibekhor@gmail.com.
- Department of Surgery, University Health Network, Toronto, ON, Canada.
- Department of Surgery, Rabin Medica Center, Petah Tikva, Israel.
- Department of Gynecology, University Health Network, Toronto, ON, Canada.
- University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Eliahu Yonathan Bekhor
Zitieren
APA
Bekhor, E. Y., Klein, E., Shmilovich, H., Marom, G., Glazer, Y., Bouchard-Fortier, G., Harris, M., & Shlomovitz, E. (2025). Self-expanding metallic stent insertion for malignant bowel obstruction secondary to gynecologic malignancies: a retrospective analysis. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-11483-6
Vancouver
Bekhor EY, Klein E, Shmilovich H, Marom G, Glazer Y, Bouchard-Fortier G, et al. Self-expanding metallic stent insertion for malignant bowel obstruction secondary to gynecologic malignancies: a retrospective analysis. Surgical Endoscopy. 2025. doi:10.1007/s00464-024-11483-6
BibTeX
@article{Bekhor2025,
author = {Bekhor, Eliahu Yonathan and Klein, Erez and Shmilovich, Hila and Marom, Gad and Glazer, Yair and Bouchard-Fortier, Genevieve and Harris, Mai and Shlomovitz, Eran},
title = {Self-expanding metallic stent insertion for malignant bowel obstruction secondary to gynecologic malignancies: a retrospective analysis},
journal = {Surgical Endoscopy},
year = {2025},
doi = {10.1007/s00464-024-11483-6}
}
EUVIMED